If you are searching for the cheapest weight loss injections in the UK, this guide is not a price comparison or a roundup of low-cost providers: it explains where Mounjaro fits, who it may be prescribed for in the UK, and what women with polycystic ovary syndrome (PCOS) need to know before treating it as a weight-loss option.
If you have PCOS and are wondering whether Mounjaro could help with weight management or insulin resistance, this guide gives you a straight, evidence-based picture: what it can and cannot do for PCOS, what the current research actually shows.
Because many women with PCOS also have overweight or obesity, some may be eligible for tirzepatide under its licensed weight-management indication. If a prescriber uses it specifically to address aspects of PCOS outside the licensed indication, that would be off-label prescribing.
This guide also discusses fertility and pregnancy points that matter enormously for this group, who can access it in the UK, how long treatment may take, what side effects to expect, and how it compares with other parts of PCOS care.
We have written this as a genuine clinical guide rather than a sales page, because PCOS, weight, and insulin resistance can affect symptoms, long-term health, and pregnancy planning, so the decision to use a treatment like Mounjaro needs honesty rather than marketing.
Is Mounjaro Licensed for PCOS?
The honest answer, and an important one, is no. Mounjaro (tirzepatide) is not licensed as a treatment for PCOS. In the UK it is licensed for type 2 diabetes and for weight management in people who meet certain criteria.
That does not mean it is never used by women with PCOS. Because many women with PCOS also have overweight or obesity, some may be eligible for tirzepatide under its licensed weight-management indication. If a prescriber uses it specifically to address aspects of PCOS outside the licensed indication, that would be off-label prescribing.
Off-label prescribing, using a licensed medicine for a purpose outside its licence, is lawful and common in UK medicine when a prescriber judges it appropriate. But it is different from Mounjaro being an approved PCOS treatment, and any page suggesting otherwise would be misleading. It is a weight and insulin-resistance tool that some women with PCOS may be suitable for, not a PCOS cure.
Why Mounjaro Weight Loss Medication Is Being Used in PCOS
The rationale is real and worth understanding, because it is about the metabolic side of PCOS rather than a direct action on the ovaries.
Most women with PCOS have some degree of insulin resistance, where the body's cells respond poorly to insulin. Insulin resistance is common in PCOS and is particularly associated with higher weight and metabolic risk.
The active ingredient tirzepatide can improve several metabolic measures while producing substantial weight loss.
In Mounjaro, this activates receptors for GIP and GLP-1, hormones involved in glucose regulation and appetite. This is how weight loss injections work: Mounjaro is a dual agonist that mimics GLP-1 and glucose dependent insulinotropic polypeptide.
The key point about how it helps is that the benefit is largely indirect. Mounjaro does not act directly on the hormonal machinery of PCOS. Instead, by reducing weight and improving insulin sensitivity, it can ease some of the downstream problems that flow from those, which is a meaningful distinction from the idea that it somehow regulates PCOS hormones itself.
What the Evidence Actually Shows About Insulin Resistance
Here is a fair summary of where the research stands, neither dismissive nor overhyped.
Weight loss helps PCOS, and that is well established. Weight loss can improve some metabolic and reproductive features of PCOS in women who are living with overweight or obesity, although the amount of weight loss associated with improvement varies between individuals.
Since Mounjaro is one of the most effective weight-loss treatments available, that alone is a plausible route to benefit. It is better understood as a medically supervised weight loss treatment, and clinical trials in broader obesity populations support that level of effectiveness rather than leaving it as theory alone.
Real-world data is encouraging. Recent UK real-world data in women with PCOS using tirzepatide are encouraging, particularly for weight loss, but these observational findings do not establish that tirzepatide treats PCOS itself.
In the SURMOUNT-1 trial in adults with obesity or overweight and a weight-related condition, average weight loss at 72 weeks ranged from 16.0% with 5 mg to 22.5% with 15 mg. These results were not specific to people with PCOS. Other weight loss medication options, such as Saxenda (liraglutide), typically result in 5% to 8% weight loss.
But the definitive evidence is not in yet. That study was real-world and observational rather than a gold-standard randomised trial, and the dedicated trials testing tirzepatide specifically for PCOS outcomes such as restoring ovulation and regular periods are still ongoing. So the honest position is that the evidence is promising and growing, particularly on weight and metabolic measures, but it is not yet proof that Mounjaro reliably treats the reproductive features of PCOS. Treat any claim that it definitely fixes PCOS with caution.
Fertility and Pregnancy: The Most Important Section
If you have PCOS and are of reproductive age, please read this part carefully, because it is where the biggest safety issues sit and where the live information online is often weakest.
Weight loss may improve ovulation and fertility in some women with PCOS. Many women with PCOS have irregular or absent ovulation, and some assume they cannot easily get pregnant. Losing weight can restart ovulation and may improve the chance of conception, and in pcos weight loss this may also be linked with improved fertility. That can be wonderful news if you are trying for a baby, but it creates a serious risk if you are not, because of the next point.
Mounjaro must not be used in pregnancy. It is contraindicated in pregnancy, and there is not enough safety data to consider it safe for a developing baby. So the combination of restored fertility and a drug that must not be taken while pregnant means contraception matters more here than almost anywhere.
The MHRA contraception warning applies. UK regulators advise that women using tirzepatide who take the oral contraceptive pill should use a backup method, such as condoms, or switch to a non-oral method, for four weeks after starting and for four weeks after each dose increase, because absorption of the pill may be affected. For women with PCOS, whose fertility may also be returning as they lose weight, this is doubly important.
If you are trying to conceive, Mounjaro is not the right treatment. It should be stopped in advance of trying for a baby, because it takes time to clear from your body and must not be used in pregnancy. If you are planning a pregnancy, tirzepatide should be stopped at least one month before a planned pregnancy. Speak to your prescriber before stopping treatment so that you can plan the change safely.
If you become pregnant while using Mounjaro, stop it and contact your prescriber or GP promptly.
How Would You Access Mounjaro With PCOS?
Because Mounjaro is not licensed for PCOS, you would not be prescribed it "for PCOS" as such. Access is usually through weight loss injections as the broader weight-management route, and a prescriber decides suitability.
For its licensed weight-management indication, Mounjaro can be used in adults with a BMI of 30 kg/m² or above, or a BMI of 27 kg/m² to below 30 kg/m² with at least one weight-related comorbidity. NHS access is more restricted and follows NICE criteria and local service arrangements, so meeting the licence criteria does not automatically mean you qualify for NHS treatment.
A full assessment looks at your health, your other medicines, whether you might be pregnant or trying to conceive, and whether treatment is appropriate and safe for you. You generally need to be over 18, and in the UK these treatments are usually only available privately unless you are referred through a specialist pathway. If your body mass index is in the healthy range, Mounjaro would generally not be suitable even if you have PCOS, and other PCOS treatments would be more appropriate. Use a regulated UK pharmacy, as counterfeit products are a known risk.
What to Realistically Expect Over Time
People often search for a week-by-week PCOS timeline, so here is an honest version, with the caveat that individual responses vary a lot.
- Early weeks: the body adjusts to the weekly injection. Appetite changes, feeling fuller sooner, fewer cravings, often show before any weight change, with reducing hunger and steadier blood sugar after meals helping with food cravings. Mild digestive effects such as nausea are most common early on.
- First couple of months: appetite regulation tends to settle into a more predictable pattern, and gradual weight change usually begins. Weight and appetite changes may become more noticeable over the following weeks and months, although individual responses vary.
- Longer term: as weight comes down and insulin sensitivity improves, some women notice PCOS-related improvements, such as more regular periods, though this varies and is driven by the weight and metabolic change rather than a direct effect on the ovaries, and the best results still depend on healthy lifestyle changes that support weight maintenance.
Even modest weight loss can be clinically meaningful, but the amount needed to improve PCOS features varies between individuals. Progress is not linear, and plateaus can occur. Some people need long-term treatment to maintain results, so expectations should be based on starting weight rather than week-by-week comparisons.
Mounjaro Alongside Other PCOS Treatments
Mounjaro would usually be one part of a wider PCOS plan, not a replacement for it.
Metformin is commonly used in PCOS, particularly when metabolic features such as insulin resistance are a concern, although its role depends on the individual's symptoms and treatment goals.
Do not stop any existing PCOS treatment, including metformin, the contraceptive pill, or anti-androgen medicines, without medical advice, and tell whoever prescribes your Mounjaro about everything else you take. Lifestyle measures remain an important part of PCOS management and are used alongside medication where appropriate.
Side Effects and When to Seek Help
The common side effects are similar to those seen with many weight loss drugs and other weight loss treatments, mainly digestive and gastrointestinal side effects such as nausea, changes in bowel habits, and reduced appetite, usually most noticeable early and after dose increases, and often easing with time.
Contact your prescriber, GP or NHS 111 if side effects are severe or persistent, if nausea or vomiting stops you eating and drinking properly, if ongoing or severe vomiting could lead to dehydration, or if anything worries you. Seek urgent help for severe, persistent abdominal pain, which can be a sign of a serious problem. And as above, if you think you might be pregnant, stop and seek advice promptly. In an emergency, call 999.
Weight loss injections are only appropriate when prescribed after review of your medical history and used under medical supervision.
A Note on "Before and After"
Searches for PCOS "before and after" results are common, and it is worth being straight about them. We are not going to show or invent transformation photos or specific results, because individual outcomes vary enormously and presenting selected results as typical would be misleading. What the evidence supports is that meaningful weight loss is achievable for many women with PCOS on tirzepatide, and that weight loss tends to improve PCOS symptoms, but your own result is individual and best discussed with your prescriber.
Key Takeaways
- Mounjaro is not licensed for PCOS, some women with PCOS access it off-label through the weight-management route.
- In the UK, private weight loss injections commonly cost about £100 to £375 per month.
- Its benefit in PCOS is mostly indirect, through weight loss and improved insulin sensitivity, not a direct hormonal effect.
- Evidence is promising, including strong recent UK weight-loss data, but not yet proof it treats PCOS reproductive symptoms.
- Fertility can return as you lose weight, and Mounjaro must not be used in pregnancy, so contraception is critical.
- If you are trying to conceive, it should be stopped in advance, on your prescriber's advice.
- Even modest weight loss can benefit some metabolic and PCOS-related outcomes, although the response varies between individuals.
- It is one part of a wider PCOS plan aimed at reaching and maintaining a healthy weight, do not stop other treatments without advice.